| Abstrakt: |
Dipyridamole sestamibi nuclear scanning (MIBI) is a commonly used test to screen for cardiac disease in patients undergoing elective abdominal aortic aneurysm (AAA) surgery. However, its routine use for all patients is controversial. The purpose of this study was to determine whether MIBI scanning could identify high-risk patients and lead to decreased myocardial infarction (MI) and cardiac death when compared with patients who did not receive MIBI scanning preoperatively. The authors reviewed 212 consecutive patients undergoing elective AAA repair between January 1990 and December 1993. Data regarding preoperative cardiac status, MIBI scan results, and cardiovascular outcomes were collected. During this period, 92 patients had MIBI scans preoperatively while 120 patients underwent AAA surgery without MIBI scanning. The average ages for these two groups were 70 ±8 and 71 ±9 years, respectively. The frequency of coronary artery disease, angina, and previous MI in the MIBI group was 47%, 26%, and 29%, respectively. In the non-MIBI group, these frequencies were 39%, 23%, and 28%, respectively. Eleven patients were identified in the MIBI group to have moderate or large reversible defects. Of these, five underwent cardiac revascularization with no morbidity. The frequency of postoperative MI and death for the MIBI group was 1.1% (1/92) and 0%, respectively. In the non-MIBI group, it was 3.3% (4/120) and 1.7% (2/120), respectively (p=0.54). Preoperative MIBI scanning identified high-risk patients for AAA surgery. Following coronary revascularization for these high-risk patients, the overall MI and mortality rates were similar to those in patients who did not receive MIBI preoperatively. [ABSTRACT FROM PUBLISHER] |
